Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 2020

View Archived Issues

Heart failure hormone has role in sepsis

NRF2 wakes sleeping tumor cells

FDA grants IND approval for phase III study of GV-971 in Alzheimer's disease

Pivotal ADVANCE-1 study of AXS-05 meets primary endpoint

FDA approves Ongentys as add-on treatment for patients with Parkinson's disease

Preclinical data support development of FX-301 for post-operative pain

Pilot study data for ZX-008 as adjunctive therapy in sunflower syndrome

Adavosertib shows clinical activity in uterine serous carcinoma

Pliant Therapeutics discovers integrin alphavbeta1 and/or alphavbeta6 antagonists

New ROMK blockers identified at Bristol-Myers Squibb

NantBioScience patents dual Wnt/beta-catenin and hedgehog signaling inhibitors

New TLR7 agonist prodrugs disclosed by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Boehringer Ingelheim identifies new plasma kallikrein inhibitors

[11C]MK-6884 useful for muscarinic receptor imaging in AD

AACR 2020: Phosphatases are yin to kinases' yang

ENTR-501 corrects metabolic abnormalities in mouse model of MNGIE

European Commission approves Fetcroja for infections due to aerobic Gram-negative bacteria

Genuv studies trametinib in phase I/IIa trial in Korea for ALS

Enrollment open in phase I/IIa study of PBCAR-269A in relapsed/refractory multiple myeloma

First-in-human data for the ChAdOx1 MERS vaccine candidate

BXCL-701 advances into phase II portion of phase Ib/II trial with pembrolizumab for tNEPC

Roche reports new 6-year data on Ocrevus in MS

FIREFISH part 2 study of risdiplam in infants with type 1 SMA meets primary endpoint

Sovateltide demonstrates improvement on mRS in acute ischemic stroke trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...